Published in J Clin Oncol on January 01, 1998
Pancreatic adenocarcinoma. J Natl Compr Canc Netw (2010) 1.52
A decision model of therapy for potentially resectable pancreatic cancer. J Surg Res (2011) 1.40
Neoadjuvant therapy in pancreatic adenocarcinoma: a meta-analysis of phase II trials. Surgery (2011) 1.32
Vanilloids in pancreatic cancer: potential for chemotherapy and pain management. Gut (2005) 1.20
Neoadjuvant GTX chemotherapy and IMRT-based chemoradiation for borderline resectable pancreatic cancer. J Surg Oncol (2011) 1.14
The role of radiotherapy in multimodal treatment of pancreatic carcinoma. Radiat Oncol (2010) 1.09
Downstaging of pancreatic carcinoma after neoadjuvant chemoradiation. Strahlenther Onkol (2009) 0.99
The role of radiation therapy in pancreas cancer. Gastrointest Cancer Res (2009) 0.99
Adjuvant therapy in pancreatic cancer. World J Gastroenterol (2001) 0.97
The role of radiotherapy in management of pancreatic cancer. J Gastrointest Oncol (2011) 0.97
Adjuvant and neoadjuvant treatment in pancreatic cancer. World J Gastroenterol (2012) 0.96
Current status of adjuvant therapy for pancreatic cancer. Oncologist (2010) 0.93
Effect of initiating a multidisciplinary care clinic on access and time to treatment in patients with pancreatic adenocarcinoma. J Oncol Pract (2010) 0.93
A single-arm, nonrandomized phase II trial of neoadjuvant gemcitabine and oxaliplatin in patients with resectable pancreas adenocarcinoma. Ann Surg (2014) 0.92
Neoadjuvant therapy of pancreatic cancer: the emerging paradigm? Oncologist (2012) 0.92
A phase I study evaluating the role of the anti-epidermal growth factor receptor (EGFR) antibody cetuximab as a radiosensitizer with chemoradiation for locally advanced pancreatic cancer. Cancer Chemother Pharmacol (2010) 0.91
A phase 1/2 and biomarker study of preoperative short course chemoradiation with proton beam therapy and capecitabine followed by early surgery for resectable pancreatic ductal adenocarcinoma. Int J Radiat Oncol Biol Phys (2014) 0.87
Laparoscopic staging and surgical treatment of pancreatic cancer. N Am J Med Sci (2013) 0.87
Treatment of unresectable, locally advanced pancreatic adenocarcinoma with combined radiochemotherapy with 5-fluorouracil, leucovorin and cisplatin. Br J Cancer (2000) 0.85
Chemoradiation in pancreatic adenocarcinoma: a literature review. Oncologist (2010) 0.85
Proposing the lymphatic target volume for elective radiation therapy for pancreatic cancer: a pooled analysis of clinical evidence. Radiat Oncol (2010) 0.84
The Role of Neoadjuvant Chemoradiation Therapy in Patients With Borderline Resectable Pancreatic Cancer With Isolated Venous Vascular Involvement. Medicine (Baltimore) (2015) 0.84
Gli3 mediates cell survival and sensitivity to cyclopamine in pancreatic cancer. Cancer Biol Ther (2010) 0.84
Challenges in the study of adjuvant chemoradiation after pancreaticoduodenectomy. Ann Surg Oncol (2010) 0.83
Endoscopic ultrasound-guided intratumoural therapy for pancreatic cancer. Can J Gastroenterol (2008) 0.83
Neoadjuvant treatment for resectable pancreatic cancer: time for phase III testing? World J Gastroenterol (2010) 0.83
Contemporary Management of Borderline Resectable and Locally Advanced Unresectable Pancreatic Cancer. Oncologist (2016) 0.83
Gemcitabine/cisplatin versus 5-fluorouracil/mitomycin C chemoradiotherapy in locally advanced pancreatic cancer: a retrospective analysis of 93 patients. Radiat Oncol (2011) 0.81
Comparison of 1-, 2-, and 3-Dimensional Tumor Response Assessment After Neoadjuvant GTX-RT in Borderline-Resectable Pancreatic Cancer. Gastrointest Cancer Res (2011) 0.81
Neoadjuvant chemoradiation in patients with pancreatic adenocarcinoma. HPB (Oxford) (2006) 0.79
Proton therapy may allow for comprehensive elective nodal coverage for patients receiving neoadjuvant radiotherapy for localized pancreatic head cancers. J Gastrointest Oncol (2013) 0.78
Perioperative Therapy for Surgically Resectable Pancreatic Adenocarcinoma. Hematol Oncol Clin North Am (2015) 0.78
The role of chemoradiation therapy in locally advanced pancreatic cancer. HPB (Oxford) (2005) 0.77
Pilot study of hepatic arterial infusion chemotherapy with gemcitabine and 5-fluorouracil for patients with postoperative liver metastases from pancreatic cancer. Exp Ther Med (2011) 0.77
Impact of preoperative therapy on patterns of recurrence in pancreatic cancer. HPB (Oxford) (2013) 0.77
Adjuvant treatment. HPB (Oxford) (2006) 0.76
To drain or not to drain? That is the question. Dig Dis Sci (2013) 0.76
Multidisciplinary neoadjuvant management for potentially curable pancreatic cancer. Cancer Med (2015) 0.76
Adjuvant/Perioperative Therapy in Pancreatic and Periampullary Cancer. Indian J Surg (2015) 0.75
Neoadjuvant therapy in patients with pancreatic cancer: a disappointing therapeutic approach? Cancers (Basel) (2011) 0.75
Pancreas club international joint symposium on pancreatic cancer 2012, Kyoto: down staging chemo±radiotherapy for borderline resectable pancreatic cancer. Korean J Hepatobiliary Pancreat Surg (2013) 0.75
Improving Survival of Pancreatic Cancer. What Have We Learnt? Indian J Surg (2015) 0.75
Hepatic arterial infusion chemotherapy for post-operative liver metastases from pancreatic cancer in a patient with leukocytopenia: A case report. Exp Ther Med (2010) 0.75
Neoadjuvant interferon-based chemoradiation for borderline resectable and locally advanced pancreas cancer: a Phase II pilot study. HPB (Oxford) (2013) 0.75
Neoadjuvant therapy for pancreatic cancer: an ongoing debate. Therap Adv Gastroenterol (2016) 0.75
Unresectable pancreatic adenocarcinoma with complete clinical response following chemoradiotherapy. Ulus Cerrahi Derg (2015) 0.75
Clinical benefits of neoadjuvant chemoradiotherapy for adenocarcinoma of the pancreatic head: an observational study using inverse probability of treatment weighting. J Gastroenterol (2016) 0.75
Biological determinants of radioresistance and their remediation in pancreatic cancer. Biochim Biophys Acta (2017) 0.75
Molecular predictors of survival after adjuvant chemotherapy for colon cancer. N Engl J Med (2001) 5.22
Streptozocin-doxorubicin, streptozocin-fluorouracil or chlorozotocin in the treatment of advanced islet-cell carcinoma. N Engl J Med (1992) 4.33
Overview of the randomized trials of radiotherapy in ductal carcinoma in situ of the breast. J Natl Cancer Inst Monogr (2010) 2.91
Cell culture of human colon adenomas and carcinomas. Cancer Res (1987) 2.68
Impact of number of nodes retrieved on outcome in patients with rectal cancer. J Clin Oncol (2001) 2.54
Designs and analysis of two-stage studies. Stat Med (1992) 2.10
Treatment tolerance of elderly cancer patients entered onto phase II clinical trials: an Illinois Cancer Center study. J Clin Oncol (1994) 1.71
Neoadjuvant chemoradiation in pancreatic and duodenal carcinoma. A Phase II Study. Cancer (1993) 1.69
Adjuvant therapy in rectal cancer: analysis of stage, sex, and local control--final report of intergroup 0114. J Clin Oncol (2002) 1.62
Establishment and characterization of human colorectal cancer cell lines. Cancer Res (1984) 1.50
Effect of lymph node retrieval rates on the utilization of adjuvant chemotherapy in stage II colon cancer. J Surg Oncol (2009) 1.49
Physicians' perceptions of the risk of being sued. J Health Polit Policy Law (1992) 1.48
Prognostic implications of c-Ki-ras2 mutations in patients with advanced colorectal cancer treated with 5-fluorouracil and interferon: a study of the eastern cooperative oncology group (EST 2292) Cancer J Sci Am (1997) 1.45
A phase II study of continuous infusion 5-fluorouracil in advanced hormone refractory prostate cancer. An Illinois Cancer Center Study. Cancer (1993) 1.44
Human T lymphocyte subpopulations: correlation between E-rosette-forming affinity and expression of the Fc receptor. J Immunol (1977) 1.39
Recommended colorectal cancer surveillance guidelines by the American Society of Clinical Oncology. J Clin Oncol (1999) 1.39
Regression analysis with missing covariate data using estimating equations. Biometrics (1996) 1.34
Indications and results of liver resection and hepatic chemoembolization for metastatic gastrointestinal neuroendocrine tumors. Surgery (2001) 1.28
A pilot study of preoperative chemoradiation for patients with localized adenocarcinoma of the pancreas. Am J Surg (1995) 1.26
Analysis of dichotomous outcome data for community intervention studies. Stat Methods Med Res (2000) 1.16
Phase I study of vinblastine and verapamil given by concurrent iv infusion. Cancer Treat Rep (1985) 1.15
Phase II trial of chemoembolization for the treatment of metastatic colorectal carcinoma to the liver and review of the literature. Cancer (1998) 1.14
Initial results of a phase II trial of high dose radiation therapy, 5-fluorouracil, and cisplatin for patients with anal cancer (E4292): an Eastern Cooperative Oncology Group study. Int J Radiat Oncol Biol Phys (1996) 1.14
Recommended guidelines for the treatment of chemotherapy-induced diarrhea. J Clin Oncol (1998) 1.11
Adjuvant active specific immunotherapy for stage II and III colon cancer with an autologous tumor cell vaccine: Eastern Cooperative Oncology Group Study E5283. J Clin Oncol (2000) 1.11
Lymphoma of the breast. Ann Surg (1981) 1.11
Issues in the analysis of repeated categorical outcomes. Stat Med (1988) 1.10
Do operations facilitate tumor growth? An experimental model in rats. Surgery (1986) 1.08
Endoscopic transrectal resection of rectal carcinomas using the urologic resectoscope. Dis Colon Rectum (1984) 1.08
Adjuvant postoperative fluorouracil-modulated chemotherapy combined with pelvic radiation therapy for rectal cancer: initial results of intergroup 0114. J Clin Oncol (1997) 1.07
Hepatocellular carcinoma. An ECOG randomized phase II study of beta-interferon and menogaril. Am J Clin Oncol (1995) 1.07
Preoperative chemoradiation for adenocarcinoma of the pancreas and duodenum. Int J Radiat Oncol Biol Phys (1994) 1.05
Multimodality therapy of localized unresectable pancreatic adenocarcinoma. Cancer (1984) 1.05
Final report of Intergroup Trial 0122 (ECOG PE-289, RTOG 90-12): Phase II trial of neoadjuvant chemotherapy plus concurrent chemotherapy and high-dose radiation for squamous cell carcinoma of the esophagus. Int J Radiat Oncol Biol Phys (1999) 1.01
Correlations between leukocyte count and absolute granulocyte count in patients receiving cancer chemotherapy. Cancer (1985) 0.98
Reactivity of lung cancer patients in leukocyte migration inhibition assays to 3-M potassium chloride extracts of fresh tumor and tissue-cultured cells derived from lung cancer. J Natl Cancer Inst (1977) 0.97
Immunological monitoring and immunotherapy in carcinoma of the lung. Int J Cancer (1976) 0.97
Protracted intravenous fluorouracil infusion with radiation therapy in the management of localized pancreaticobiliary carcinoma: a phase I Eastern Cooperative Oncology Group Trial. J Clin Oncol (1995) 0.96
Long term use of megestrol acetate by cancer survivors for the treatment of hot flashes. Cancer (1998) 0.96
Workshop on partial breast irradiation: state of the art and the science, Bethesda, MD, December 8-10, 2002. J Natl Cancer Inst (2004) 0.95
Glutathione S-transferases in human prostate. Biochim Biophys Acta (1987) 0.95
Long-term follow-up of local excision and radiation therapy for invasive rectal cancer. Dis Colon Rectum (1995) 0.95
Pharmacokinetics and pharmacodynamics of oltipraz as a chemopreventive agent. Clin Cancer Res (1995) 0.94
Using a hypothetical case to measure differences in treatment aggressiveness among physicians in Canada, Germany and the United States. Wien Klin Wochenschr (1998) 0.94
CT-guided needle localization for intraoperative biopsy of the head and neck. Laryngoscope (1990) 0.94
How long is the five centimeter margin? Surg Gynecol Obstet (1986) 0.93
Management of cancer treatment-related diarrhea. Issues and therapeutic strategies. J Pain Symptom Manage (2000) 0.93
A phase II study of gemcitabine and cisplatin in patients with advanced hepatocellular carcinoma. Trop Gastroenterol (2006) 0.92
Temsirolimus combined with sorafenib in hepatocellular carcinoma: a phase I dose-finding trial with pharmacokinetic and biomarker correlates. Ann Oncol (2013) 0.91
A phase II trial of perifosine in locally advanced, unresectable, or metastatic pancreatic adenocarcinoma. Am J Clin Oncol (2007) 0.91
Dietary vitamin A intake and the risk of mortality among children. Am J Clin Nutr (1994) 0.91
Depletion of protein kinase Cepsilon in normal and scleroderma lung fibroblasts has opposite effects on tenascin expression. Arthritis Rheum (2001) 0.89
NCCN Colorectal Cancer Practice Guidelines. The National Comprehensive Cancer Network. Oncology (Williston Park) (1996) 0.89
Clodronate. A randomized study in the treatment of cancer-related hypercalcemia. Arch Intern Med (1987) 0.88
A phase II study of irinotecan with 5-fluorouracil and leucovorin in patients with previously untreated gastric adenocarcinoma. Ann Oncol (2001) 0.88
Recurrent typhlitis. A disease resulting from aggressive chemotherapy. Dis Colon Rectum (1989) 0.85
Phase I/II trial of tamoxifen with or without fenretinide, an analog of vitamin A, in women with metastatic breast cancer. J Clin Oncol (1993) 0.85
Attitudinal barriers to participation in oncology clinical trials: factor analysis and correlates of barriers. Eur J Cancer Care (Engl) (2014) 0.85
Endoscopic transrectal resection of rectal tumors. Cancer (1986) 0.84
Pleural peritoneal shunts for the treatment of malignant pleural effusions. Surg Gynecol Obstet (1982) 0.84
Sampling of grossly benign breast reexcisions: a multidisciplinary approach to assessing adequacy. Am J Surg Pathol (1999) 0.83
Meta-analysis of binary data: which within study variance estimate to use? Stat Med (2001) 0.83
Vitamin A supplementation and dietary vitamin A in relation to the risk of xerophthalmia. Am J Clin Nutr (1993) 0.83
Subcutaneous seeding of pancreatic carcinoma along a transhepatic biliary catheter tract. Br J Radiol (1983) 0.83
A phase II study of pegylated-camptothecin (pegamotecan) in the treatment of locally advanced and metastatic gastric and gastro-oesophageal junction adenocarcinoma. Cancer Chemother Pharmacol (2008) 0.83
A phase II clinical trial of echinomycin in metastatic soft tissue sarcoma. An Illinois Cancer Center Study. Invest New Drugs (1995) 0.82
The effects of bevacizumab on postoperative complications in patients undergoing colorectal and pancreatic cancer resection. J Surg Oncol (2010) 0.82
Modulation of 5-iodo-2'-deoxyuridine metabolism and cytotoxicity in human bladder cancer cells by fluoropyrimidines. Biochem Pharmacol (1985) 0.82
Brief communication: technical modifications of the human agarose microdroplet leukocyte migration inhibition assay. J Immunol Methods (1978) 0.82
Carcinoma of the lung: immunotherapy with intradermal BCG and allogeneic tumor cells. Int J Radiat Oncol Biol Phys (1980) 0.82
Maintenance etidronate in the prevention of malignancy-associated hypercalcemia. Arch Intern Med (1987) 0.82
Percutaneous transhepatic cholangiography, drainage, and biopsy in patients with malignant biliary obstruction. An alternative to surgery. Am J Surg (1985) 0.82
Optical imaging of breast tumor by means of continuous waves. Adv Exp Med Biol (1997) 0.82
Lymphokine-activated killer cell suppressor factor in malignant effusions. Arch Surg (1991) 0.81
Genetic variation in radiation and platinum pathways predicts severe acute radiation toxicity in patients with esophageal adenocarcinoma treated with cisplatin-based preoperative radiochemotherapy: results from the Eastern Cooperative Oncology Group. Cancer Chemother Pharmacol (2011) 0.81
Retrorectal cyst-hamartomas: CT diagnosis. J Comput Assist Tomogr (1986) 0.81
An epidemiologic and demographic study of inflammatory bowel disease in black patients. Am J Dig Dis (1974) 0.80
Long-term pulmonary toxicity of multiagent chemotherapy including bleomycin and cyclophosphamide in osteosarcoma survivors. Med Pediatr Oncol (1996) 0.80
Specificity of delayed cutaneous hypersensitivity reactions to extracts of human tumor cells. J Natl Cancer Inst (1978) 0.80
Demonstration of specific cell-mediated anti-tumor immunity in lung cancer to autologous tissue extracts. Int J Cancer (1978) 0.79
Control of bleeding esophageal varices by transabdominal esophageal transection, gastric devascularization, and splenectomy. Surg Gastroenterol (1984) 0.79
Radiation-induced intestinal injury. Clin Plast Surg (1993) 0.79
Phase II trial of prolonged continuous infusion of 5-fluorouracil and interferon-alpha in patients with advanced pancreatic cancer. Eastern Cooperative Oncology Group Protocol 3292. Am J Clin Oncol (1996) 0.79
Is percutaneous nephrostomy for hydronephrosis appropriate in patients with advanced cancer? Am J Surg (1988) 0.79
Delayed breast abscesses after lumpectomy and radiation therapy. Am Surg (1990) 0.78
Lorazepam-enhancement of the antiemetic efficacy of dexamethasone and promethazine. A placebo-controlled study. Am J Clin Oncol (1994) 0.78
A pilot trial of suramin in metastatic breast cancer to assess antiangiogenic activity in individual patients. Oncology (2000) 0.78
Prevention of rat colon cancer metastases by perioperative immunostimulation. Surgery (1984) 0.78
In vitro killing of human malignant mesothelioma by photodynamic therapy. J Surg Res (1990) 0.78
Intratumoral rIL2-based immunotherapy in B16 melanoma. J Surg Res (1992) 0.78
Treatment of squamous cell esophageal cancer with topotecan: an Eastern Cooperative Oncology Group Study (E2293). Am J Clin Oncol (2000) 0.77